Akebia Therapeutics, Inc. AKBA

Healthcare — Drug Manufacturers Specialty & Generic

0.90 (0.02) (2.17%) as of 25 Sep

Market cap: $254.7M
P/E: 0.0×

Follow AKBA

Insider Buys (last 12m)

Insider Buys alert about insiders buying in the last 12 month

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

	Dec '25	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16
Cash and Short Term Investments	184.84	51.87	42.93	90.47	149.80	228.70	147.45	104.64	317.79	260.34
Receivables	47.03	34.37	39.29	40.28	51.58	66.85	39.11	233.66	34.22	33.82
Inventory	15.61	16.24	15.69	21.57	36.63	61.02	116.35	114.25	—	—
Total current assets	252.96	113.83	118.15	185.18	271.15	371.44	309.53	468.28	358.36	296.32
Property, Plant, Equpment (Net)	1.22	2.20	3.63	5.21	6.75	8.62	10.38	8.02	3.62	2.61
Goodwill and Intangible Assets (Total)	59.04	59.04	95.09	131.13	167.17	199.22	346.27	383.21	—	—
Long-term assets (Other)	59.68	37.38	12.42	5.37	50.42	37.98	75.99	137.04	2.27	1.28
Total non-current assets	123.61	106.84	123.55	170.87	258.20	272.70	461.67	528.27	5.89	3.90
Total Assets	376.57	220.67	241.70	356.05	529.35	644.14	771.20	996.54	364.25	300.22
Accounts Payable	21.19	15.18	14.64	18.02	33.59	41.31	39.22	42.80	7.00	2.04
Accrued Expenses	121.72	63.46	67.74	75.78	109.01	130.62	129.07	150.92	52.44	30.26
Current Part of Debt	—	—	17.50	32.00	97.54	5.00	5.00	15.00	—	0.00
Current Revenue (Deferred)	2.68	0.00	0.00	3.74	20.91	15.21	39.83	56.98	81.67	81.97
Other current liabilities	17.36	2.27	—	75.00	125.00	141.00	164.00	208.00	133.00	114.00
Total current liabilities	162.94	80.91	99.87	129.54	261.05	187.15	208.12	265.69	141.11	114.27
Long Term Debt (Total)	48.25	38.69	17.18	34.08	87.00	96.38	75.81	—	—	0.00
Non-current Revenue (Deferred)	—	—	43.30	43.30	21.47	25.35	33.12	58.72	100.55	117.80
Long Term Tax Liability (Deferred)	—	—	—	—	—	—	(6.63)	6.63	—	—
Non-current Liabilities (Other)	132.77	146.70	102.99	114.95	139.11	63.03	31.87	29.57	0.02	0.03
Total non-current liabilities	181.02	188.94	172.42	221.29	194.29	209.38	168.33	94.92	100.57	117.83
Total liabilities	343.96	269.86	272.29	350.82	455.34	396.52	376.44	360.61	241.67	232.10
Additional Paid In Capital	1,716.31	1,629.17	1,578.36	1,562.25	1,536.80	1,425.12	1,188.81	1,150.58	493.82	365.30
Common Stock (Net)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	—
Retained Earnings	(1,683.70)	(1,678.36)	(1,608.95)	(1,557.02)	(1,462.80)	(1,177.51)	(794.05)	(514.39)	(370.81)	(297.14)
Common Equity (Total)	32.61	(49.18)	(30.58)	5.23	74.01	247.62	394.76	635.93	122.57	68.12
Shareholders Equity (Total)	32.61	(49.18)	(30.58)	5.23	74.01	247.62	394.76	635.93	122.57	68.12
Shareholders Equity and Liabilities (Total)	376.57	220.67	241.70	356.05	529.35	644.14	771.20	996.54	364.25	300.22
Shares (Common)	265.43	224.85	194.58	184.14	177.00	148.07	121.68	116.89	47.61	38.62
Shareholders Equity (Tangible)	(26.43)	(108.23)	(125.67)	(125.90)	(93.16)	48.40	48.49	252.72	122.57	68.12
Net Debt	(136.59)	(13.18)	(8.24)	(24.39)	34.74	(127.32)	(66.64)	(89.64)	(317.79)	(260.34)
Total Debt	48.25	38.69	34.68	66.08	184.54	101.38	80.81	15.00	—	0.00

Fold the line items

In millions of $ except per-share values · columns are period end dates

Powerpack

Full quarterly history

Analyst estimates

Unlimited screener

Unlimited Excel

Unlimited follows

Akebia Therapeutics, Inc. AKBA